Marshall Wace, LLP Berkeley Lights, Inc. Transaction History

Marshall Wace, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.9 - $3.58 $60,414 - $113,833	31,797 New	31,797 $85,000
Q2 2022 Aug 15, 2022	SELL	$3.77 - $7.34 $70,996 - $138,226	-18,832 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.12 - $19.26 $71,285 - $268,156	-13,923 Reduced 42.51%	18,832 $134,000
Q4 2021 Feb 14, 2022	SELL	$17.39 - $25.74 $1.46 Million - $2.16 Million	-83,953 Reduced 71.93%	32,755 $595,000
Q3 2021 Nov 15, 2021	BUY	$19.5 - $50.03 $2.28 Million - $5.84 Million	116,708 New	116,708 $2.28 Million
Q1 2021 May 17, 2021	SELL	$44.33 - $89.26 $4.57 Million - $9.2 Million	-103,059 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$70.38 - $106.0 $7.25 Million - $10.9 Million	103,059 New	103,059 $9.22 Million

2.22M

Ticker BLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,283,904
Market Cap $55.3M
Description
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and applic...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.